Key result
A 64-year-old man with chronic hepatitis C developed atrial fibrillation and giant negative T waves with apical hypertrophy during interferon-alpha therapy, which subsided after discontinuation.
Population
1 64-year-old man with chronic active hepatitis C, premature ventricular contracture, duodenal ulcer, and…
Design
Case_report
Follow-up
up to 2.5 years
Authors
Loading...
May suggest monitoring for AF during interferon-alpha; leaves open causality and incidence in hepatitis C.
Case Report (n=1)
Cardiovascular toxicity, including atrial fibrillation and giant negative T waves, should be carefully monitored during interferon-alpha therapy, especially in patients with minor pre-existing cardiac conditions.
Fujiwara et al. (2001) conducted a case report in Chronic Hepatitis C (n=1). Interferon-alpha 2b was evaluated on Development of cardiovascular adverse reactions. A 64-year-old man with chronic hepatitis C developed atrial fibrillation and giant negative T waves with apical hypertrophy during interferon-alpha therapy, which subsided after discontinuation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: